Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 52 Brain Neoplasms 50 Carcinoma, Non-Small-Cell Lung 48 Neoplasm Metastasis 29 Lung Neoplasms 29 Breast Neoplasms 23 Pancreatic Neoplasms 16 Melanoma 15 Carcinoma, Renal Cell 14 Carcinoma, Hepatocellular 13 Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 8 Urinary Bladder Neoplasms 7 Small Cell Lung Carcinoma 7 Colorectal Neoplasms 7 Kidney Neoplasms 5 Liver Neoplasms 4 Glioblastoma 4 Uveal Melanoma 3 Triple Negative Breast Neoplasms 3 Spinal Cord Neoplasms 3 Sarcoma 3 Prostate Cancer Metastatic 3 NSCLC 3 Meningioma 3 Hematologic Neoplasms 3 Head and Neck Neoplasms 3 Gastrointestinal Neoplasms 3 Carcinoma, Transitional Cell 3 Adenocarcinoma 3

Interventions

Bevacizumab 2 neratinib 1 brigatinib 1 Sufentanil 1 Radiosurgery 1 Mn-PyC3A 1 Losartan 1 HDAC-42 1 Cochlear Implants 1 Aspirin 1 ((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroma, Acoustic × Radiosurgery × 1 year × Clear all

NCT05702749 2026-03-24

VS PREHAB

Medical College of Wisconsin

Phase NA Recruiting

Neuroma, Acoustic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡